Chlamydia

11

Review clinical trials related to Chlamydia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Healthy Expectancy Through Routine Antenatal STI Screening

This study will evaluate whether routine screening and treatment for two common sexually transmitted infections, chlamydia and gonorrhoea, during pregnancy can reduce preterm birth and other poor birth outcomes in Botswana, and whether this approach is affordable and cost-effective for the health system. About 2,000 pregnant women attending their first antenatal care visit at up to 10 government clinics in Botswana will be invited to join the study. All women will first receive the usual antenatal care services provided in Botswana, including routine health checks and HIV and syphilis testing. Women who enroll in the study will be randomly assigned to one of two groups: 1. Standard of care group: Women receive routine antenatal care only. 2. Intervention group: In addition to routine antenatal care, women are screened for chlamydia and gonorrhoea using self-collected vaginal swabs at their first antenatal care visit and again in the third trimester. The main outcome of the study is whether screening and treating chlamydia and gonorrhoeae reduces preterm birth (before 37 weeks). Other outcomes include low birth weight, very preterm birth, and maternal health conditions.

Participants needed: 2,000
Trial details
Age: 15+Biological sex: FemaleType: InterventionalSponsor: Adriane WynnUpdated: Jul 2, 2026Locations: 1
Eligibility criteria

Asymptomatic for cervicovaginitis at first ANC (i.e., not syndromically treated... [+6]

Status: Not yet recruiting

Improving Clinic Delivery of HIV-related Anal Health Services

This project will test ways to reduce stigma in healthcare settings so that more providers offer, and more patients receive, important anal sex-related HIV services, including anorectal sexually transmitted infection (STI) testing, preventive medications, and cancer screening. By evaluating these stigma-reduction strategies in eight clinics in the Mississippi Delta, a region with high rates of HIV and STIs, the research team will learn whether and how these approaches work to improve access to care. The results will help guide healthcare systems in using the most effective methods to reduce stigma, making it easier for people to get prevention services and improving public health.

Participants needed: 8
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Albert Einstein College of MedicineUpdated: Jun 3, 2026Locations: 1
Eligibility criteria

employed at one of eight Coastal Family Health Center clinics at the time of the... [+3]

Staff or patients who are unable to provide informed consent (e.g., significant... [+2]

Status: Recruiting

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

The goal of this open-label, randomized trial is to assess the efficacy of doxycycline prophylaxis in reducing incidences of bacterial sexually transmitted infections (STIs) among adolescent and young adult females while also evaluating acceptability and antimicrobial resistance in order to inform public health policy.

Participants needed: 760
Trial details
Phase: Phase 4Age: 13-29Biological sex: FemaleType: InterventionalSponsor: WestatUpdated: May 15, 2026Locations: 13
Eligibility criteria

Age 13-29 years, inclusive; [+6]

Is male; [+8]

Status: Recruiting

Effectiveness of Relationship Education for Reducing HIV Incidence Among Men Who Have Sex With Men

The purpose of this study is to upgrade an existing relationship education and HIV prevention program. This program is designed for gay, bisexual, queer, and transgender and non-binary people who partner with cisgender men. This means the program is designed for gay, bisexual and queer men, including both cisgender and transgender men. It is also designed for transgender and non-binary people who partner with cisgender men, including both transfeminine and transmasculine people. The investigators aim to test the effectiveness of this updated program among couples and single people. Participants will complete online surveys and get tested for Chlamydia and Gonorrhea. Participants will be tested for urethral and rectal Chlamydia and Gonorrhea. Participants will also complete at-home point-of-care HIV testing, with confirmatory testing for preliminary positive results. They will also participate in our program on relationship education and HIV prevention. Study staff will follow up with participants for up to 2 years. All participants will be randomized into one of two different conditions: the all2GETHER program or no program. "Randomized" means that it is completely up to chance which condition participants will be put into. Participants have a 50% chance of being assigned to either condition, similar to a coin toss. Participants should expect that they will be in this research study for 2 years. Participation in this study will be done remotely - participants will never need to come into a research lab.

Participants needed: 5,000
Trial details
Age: 16-34Biological sex: AllType: InterventionalSponsor: Northwestern UniversityUpdated: May 8, 2026Locations: 1
Eligibility criteria

Cisgender men, transgender women and men, non-binary individuals [+8]

Status: Recruiting

A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities

This study includes testing for four STIs (chlamydia, gonorrhea, syphilis, and HIV) at no cost. If positive, individual subjects will also be counseled and offered options for treatment for themselves and their sex partners that may include no cost expedited treatment and the option to be rescreened 3 months after treatment.

Participants needed: 2,322
Trial details
Age: 15-26Biological sex: AllType: InterventionalSponsor: Tulane UniversityUpdated: May 5, 2026Locations: 1
Eligibility criteria

Identifies as African American or Black [+3]

Unwilling or unable to provide informed consent [+4]

Status: Not yet recruiting

Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans

Opioid use disorder (OUD) confers a higher risk of acquiring and transmitting infectious diseases, which may have long-term health consequences in Veterans. Treatment of OUD with medication assisted therapy is highly effective, however this often occurs independently of infectious diseases care. This project will test out a new model that combines infectious diseases and OUD care within one VA clinic appointment. This new care model may improve the health of Veterans and reduce cost and time required for Veterans who often need to attend multiple outpatient appointments.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: VA Office of Research and DevelopmentUpdated: Apr 24, 2026Locations: 1
Eligibility criteria

US Veteran [+6]

Severe medical or psychiatric disability making participation unsafe [+2]

Status: Not yet recruiting

Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland

The main goal of the observational study is to evaluate participants' satisfaction with free HIV and sexually transmitted infection (STI) testing and counselling offered by the cities of Lucerne and Zurich, Switzerland to young people and people with low incomes. Counselling and testing can be accessed without participating in the study arm of the project.

Participants needed: 1,800
Trial details
Age: 16+Biological sex: AllType: ObservationalSponsor: University of ZurichUpdated: Apr 8, 2026
Eligibility criteria

taking part in the pilot programmes [+2]

not eligible for the pilot programmes [+2]

Status: Recruiting

The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.

The objective of this research is to evaluate the efficacy and safety of doxycycline in MSM for preventing sexually transmitted infections (gonorrhea, chlamydia, and syphilis) in Thailand Participation in this study will last approximately 12 weeks and will include 2-3 clinic visits, along with 10-11 follow-up phone contacts over a period of 11 weeks.

Participants needed: 400
Trial details
Phase: Phase 4Age: 18-60Biological sex: MaleType: InterventionalSponsor: Bangrak STIs CenterUpdated: Feb 9, 2026Locations: 1
Eligibility criteria

History of allergy to tetracycline-class antibiotics

Status: Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capacity often obscure etiologies and transmission dynamics. This knowledge gap hinders the design of effective prevention and control strategies. RACSMEI will improve understanding across multiple pathogens using a multidisciplinary One Health approach. We will answer key questions on burden, ecology, transmission and population immune status to inform targeted and culturally appropriate interventions. The project combines a nationally representative One Health survey, social-science methods, and multiplex, diverse diagnostics to efficiently test for 57 priority pathogens, including zoonotic and vector-borne agents, vaccine-preventable and elimination-targeted diseases, enteric, respiratory, and environmentally transmitted pathogens and selected neglected tropical diseases and parasites relevant to Cambodia. Mathematical modelling will reconstruct and forecast transmission dynamics and assess the potential impact of future public-health strategies. By integrating intersectoral data and innovative methods, RACSMEI will generate actionable evidence for public-health authorities, support precision One Health interventions, and help reduce disease burden in affected communities. The project also aims to ensure the transferability of methods and insights to other countries facing similar challenges.

Participants needed: 10,000
Trial details
Age: 2-75Biological sex: AllType: ObservationalSponsor: Institut Pasteur du CambodgeUpdated: Jan 22, 2026Locations: 1
Eligibility criteria

Residency in the village for more than 6 months; [+3]

Unable to understand or consent; [+3]

Status: Recruiting

Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision

The goal of this interventional study is to provide more access to STI testing for patients who seek abortion care through telemedicine, particularly for those whose access to STI testing is otherwise limited. The main questions it aims to answer are: What is the acceptability, feasibility, and utilization of self-collected STI screening at the time of telemedicine medication abortion provision? How does the uptake of such a service among patients receiving telemedicine abortion care compare to the population of patients who seek in-person medication abortion care? What are the positivity rates for STIs in among patients receiving telemedicine medication abortion care compared to the positivity rates for a contemporaneous, in-clinic population? What is the average time to between testing and treatment for patients who test positive for an STI using the self-collection service? Researchers will compare the intervention group to a contemporaneous, in-clinic population on uptake of STI screening, as well as on positivity rates for the STIs tested. Participants will be asked to perform self-swab collection for STI testing for gonorrhea, chlamydia, and trichomonas. They will be instructed to send their specimens to a lab using prepaid postage. Upon completion of sample collection and shipping, they will be asked to complete a survey assessing basic demographic information, as well as acceptability and feasibility of the intervention. Patients who test positive for an STI will be promptly provided/referred to treatment.

Participants needed: 75
Trial details
Age: 14+Biological sex: FemaleType: InterventionalSponsor: Queen's Medical CenterUpdated: Jun 26, 2025Locations: 1
Eligibility criteria

Patients of the Queen Medical Center Options Center clinic seeking telemedicine... [+4]

Home address that is not located in the state of Hawai'i [+2]

Status: Recruiting

Vienna HIV Infection Via Sex Study

The main objective of this prospective observational cohort study is to investigate the epidemiology, the risk factors and ultimately the incidence of novel HIV infections among individuals at high risk for acquiring HIV via sex practices.

Participants needed: 500
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Medical University of ViennaUpdated: Apr 13, 2022Locations: 1Duration: 5 Years
Eligibility criteria

High risk for acquiring HIV defined as followed: HIV-negative MSM and transgende... [+2]